Last updated: May 18, 2026
Top anti-aging peptides
1. GHK-Cu (copper tripeptide-1)
Modulates 4,000+ human genes related to tissue regeneration, antioxidant defense, and anti-inflammatory pathways. Plasma levels decline ~60% between ages 20-60. Restoration via topical or injectable use is the basis of cosmetic and longevity applications.
2. Epitalon (Epithalon)
Synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from epithalamin. Studied for telomerase activation, telomere length preservation, and circadian rhythm normalization. Khavinson research showed reduced mortality in elderly human cohorts.
3. Thymalin
Thymic peptide bioregulator studied for immune restoration and overall longevity. Khavinson research describes reduced mortality and improved immune function in elderly subjects.
4. MOTS-c (mitochondrial-derived peptide)
Mitochondrial-encoded peptide regulating metabolism, insulin sensitivity, and cellular stress response. Levels decline with age. Animal models show life-extension effects.
5. CJC-1295 + Ipamorelin (GH support)
Restores age-declined GH/IGF-1 levels to youthful range. Indirect anti-aging via GH-mediated tissue maintenance, body composition, and sleep architecture.
6. Khavinson Bioregulators (general)
Family of tissue-specific short peptides (4-5 amino acids each) developed by Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. Each bioregulator targets a specific organ system (heart, lungs, prostate, etc.) with claimed gene-expression effects.
Khavinson research overview
Vladimir Khavinson’s research group has published extensively (over 200 papers) on peptide bioregulators since the 1970s. Cohort studies in elderly populations show reduced all-cause mortality and improved organ-system function. The research base is primarily Russian-language and uses different methodological standards than Western clinical trials.
Evidence quality ranking
- GHK-Cu: Strongest evidence base, including Western studies. Cosmetic skin applications well-documented.
- GH-releasing peptides: Strong mechanistic evidence and clinical use for GH deficiency.
- Epitalon, MOTS-c: Promising animal models, growing human data.
- Khavinson bioregulators: Substantial Russian research, limited Western replication.
Realistic expectations
Anti-aging peptides produce gradual effects measured over months-to-years rather than acute changes. Mechanisms target underlying biology (gene expression, mitochondrial function, telomere length) rather than producing immediately visible effects. The most evidence-based use is restoration of declined molecules (GH, IGF-1, GHK-Cu) to youthful levels rather than expectation of dramatic rejuvenation.
Which anti-aging peptide has the most evidence?<br />
GHK-Cu has the broadest published evidence base, including Western studies for skin and wound healing. GH-releasing peptides have strong clinical use for GH deficiency.
Does epitalon really activate telomerase?<br />
Research from the Khavinson group shows this effect. Western groups have replicated some findings but the methodological standards differ.
Can multiple anti-aging peptides be stacked?<br />
Yes — different mechanisms suggest combination is sensible. Common stack: GHK-Cu (skin/regenerative) + Epitalon (cellular) + Thymalin (immune) + CJC-1295/Ipamorelin (GH/IGF-1).
How long do anti-aging peptide cycles last?<br />
Most research-community protocols use 10-20 day cycles 2-4 times per year, rather than continuous use. This is based on Khavinson’s bioregulator protocols.